Tumor-associated DC dysfunction. Tumor cells and the tumor microenvironment can cause quantitative and qualitative defects in DCs, which are mostly mediated by soluble factors. CTL, cytotoxic T lymphocyte; M-CSF, macrophage colony-stimulating factor; MHC I, major histocompatibility complex class I; TCR, T-cell receptor.